Can olfactory bulb biopsy be justified for the diagnosis of Parkinson’s disease? Comments on “olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body di... by Parkkinen, L, Silveira-Moriyama, L, Holton, J, Lees, A, Revesz, T

Opsoclonus myoclonus syndrome associated with GQ1b antibodies. by Morales-Briceño, H, Rodríguez-Violante, M, Cervantes-Arriaga, A, Irani, SR, Lees, A, Silveira-Moriyama, L

Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease. by Djamshidian, A, Jha, A, O'Sullivan, S, Silveira-Moriyama, L, Jacobson, C, Brown, P, Lees, A, Averbeck, B

Concomitant progressive supranuclear palsy and multiple system atrophy: More than a simple twist of fate? by Silveira-Moriyama, L, González, A, O'Sullivan, S, Williams, D, Massey, L, Parkkinen, L, Ahmed, Z, de Silva, R, Chacón, J, Revesz, T, Lees, A, Holton, J

Parkin disease: a clinicopathologic entity? by Doherty, K, Silveira-Moriyama, L, Parkkinen, L, Healy, D, Farrell, M, Mencacci, N, Ahmed, Z, Brett, F, Hardy, J, Quinn, N, Counihan, T, Lynch, T, Fox, Z, Revesz, T, Lees, A, Holton, J